These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 8514387

  • 1. Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins.
    Zhan Y, Yang J, Cheers C.
    Infect Immun; 1993 Jul; 61(7):2841-7. PubMed ID: 8514387
    [Abstract] [Full Text] [Related]

  • 2. Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts.
    Zhan Y, Kelso A, Cheers C.
    Infect Immun; 1995 Mar; 63(3):969-75. PubMed ID: 7868269
    [Abstract] [Full Text] [Related]

  • 3. Cytokine production in the murine response to brucella infection or immunization with antigenic extracts.
    Zhan Y, Kelso A, Cheers C.
    Immunology; 1993 Nov; 80(3):458-64. PubMed ID: 8288319
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Th1/Th2-Related Immune Response against Recombinant Proteins of Brucella abortus Infection in Mice.
    Im YB, Park WB, Jung M, Kim S, Yoo HS.
    J Microbiol Biotechnol; 2016 Jun 28; 26(6):1132-9. PubMed ID: 27012238
    [Abstract] [Full Text] [Related]

  • 5. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308.
    Fernandes DM, Jiang X, Jung JH, Baldwin CL.
    FEMS Immunol Med Microbiol; 1996 Dec 31; 16(3-4):193-203. PubMed ID: 9116636
    [Abstract] [Full Text] [Related]

  • 6. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
    Oliveira SC, Harms JS, Banai M, Splitter GA.
    Cell Immunol; 1996 Sep 15; 172(2):262-8. PubMed ID: 8964089
    [Abstract] [Full Text] [Related]

  • 7. Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus.
    Zaitseva MB, Golding H, Betts M, Yamauchi A, Bloom ET, Butler LE, Stevan L, Golding B.
    Infect Immun; 1995 Jul 15; 63(7):2720-8. PubMed ID: 7790090
    [Abstract] [Full Text] [Related]

  • 8. Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase.
    Im YB, Shim S, Park WB, Kim S, Yoo HS.
    Microb Pathog; 2017 Sep 15; 110():7-13. PubMed ID: 28629726
    [Abstract] [Full Text] [Related]

  • 9. Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.
    Oliveira SC, Zhu Y, Splitter GA.
    Immunology; 1994 Dec 15; 83(4):659-64. PubMed ID: 7875746
    [Abstract] [Full Text] [Related]

  • 10. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT, Arayan LT, Huy TXN, Reyes AWB, Min W, Lee HJ, Park SJ, Chang HH, Kim S.
    Vaccine; 2018 May 17; 36(21):3027-3033. PubMed ID: 29678458
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms.
    Zhan Y, Liu Z, Cheers C.
    Infect Immun; 1996 Jul 17; 64(7):2782-6. PubMed ID: 8698508
    [Abstract] [Full Text] [Related]

  • 12. Endogenous gamma interferon and interleukin-10 in Brucella abortus 2308 infection in mice.
    Fernández-Lago L, Monte M, Chordi A.
    FEMS Immunol Med Microbiol; 1996 Sep 17; 15(2-3):109-14. PubMed ID: 8880135
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
    Huy TXN, Bernardo Reyes AW, Vu SH, Arayan LT, Hop HT, Min W, Lee HJ, Lee JH, Kim S.
    Microb Pathog; 2020 Jun 17; 143():104137. PubMed ID: 32169487
    [Abstract] [Full Text] [Related]

  • 14. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.
    Zhan Y, Cheers C.
    Infect Immun; 1995 Apr 17; 63(4):1387-90. PubMed ID: 7890399
    [Abstract] [Full Text] [Related]

  • 15. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug 17; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte proliferation in response to Brucella abortus 2308 or RB51 antigens in mice infected with strain 2308, RB51, or 19.
    Stevens MG, Olsen SC, Pugh GW.
    Infect Immun; 1994 Oct 17; 62(10):4659-63. PubMed ID: 7927736
    [Abstract] [Full Text] [Related]

  • 17. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection.
    Baldwin CL, Parent M.
    Vet Microbiol; 2002 Dec 20; 90(1-4):367-82. PubMed ID: 12414157
    [Abstract] [Full Text] [Related]

  • 18. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.
    Muñoz-Montesino C, Andrews E, Rivers R, González-Smith A, Moraga-Cid G, Folch H, Céspedes S, Oñate AA.
    Infect Immun; 2004 Apr 20; 72(4):2081-7. PubMed ID: 15039330
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Brucella abortus antigen preparations for in vitro stimulation of immune bovine T-lymphocyte cell lines.
    Wyckoff JH, Howland JL, Confer AW.
    Vet Immunol Immunopathol; 1993 Feb 20; 36(1):45-64. PubMed ID: 8447086
    [Abstract] [Full Text] [Related]

  • 20. Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice.
    Brandão AP, Oliveira FS, Carvalho NB, Vieira LQ, Azevedo V, Macedo GC, Oliveira SC.
    Clin Dev Immunol; 2012 Feb 20; 2012():589494. PubMed ID: 22194770
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.